To consider ITGB2 as a potential marker for the distinction of the two subgroups of DS is quite reasonable because the CNV of ITGB2 has different distribution patterns in patients with and without AVSD [87], validating our prediction. Here, ITGB2 is linked to Dravet syndrome.